Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec;21(12):7200-7201.
doi: 10.1111/jocd.14936. Epub 2022 Nov 5.

Comment on: Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know

Ralph M Trüeb  1 , Ngoc-Nhi C Luu  1 , Natalia Caballero Uribe  1 , Antonia Régnier  1
Affiliations
Comment

Comment on: Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know

Ralph M Trüeb et al. J Cosmet Dermatol. 2022 Dec.
No abstract available

Keywords: antiandrogen treatment; bicalutamide; ethical issue; female pattern hair loss; hepatic toxicity.

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Carvalho RM, Santos LDN, Ramos PM, et al. Bicalutamide and the new perspectives for female pattern hair loss treatment: what dermatologists should know. J Cosmet Dermatol. 2022. 10.1111/jocd.14773
    1. O'Bryant CL, Flaig TW, Utz KJ. Bicalutamide-associated fulminant hepatotoxicity. Pharmacotherapy. 2008;28(8):1071-1075.
    1. Trüeb RM. The Difficult Hair Loss Patient. Guide to Successful Management of Alopecia and Related Conditions. Springer Heidelberg; 2015.
    1. Moltz L, Schwartz U, Hammerstein J. Clinical use of antiandrogens in the female article in German]. Gynakologe. 1980;13:1-17.
    1. Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol. 2002;146:992-999.

LinkOut - more resources